MBX Biosciences
$63.43
24
+$1.70+2.76% 14:56 Today
Statistics
Day High
63.68
Day Low
60.66
52W High
72.64
52W Low
9.63
Volume
54,741
Avg. Volume
741,662
Mkt Cap
3.05B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.88
-0.74
-0.61
-0.47
Expected EPS
-0.876754
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-86.97MNet Income
Analyst Ratings
84.60Average Price Target
The highest estimate is 91.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MBX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
Show more...
CEO
Steve Hoerter
Employees
63
Country
United States
ISIN
US55287L1017
Listings
0 Comments
Share your thoughts
FAQ
What is MBX Biosciences stock price today?▼
The current price of MBX is $63.43 USD — it has increased by +2.76% in the past 24 hours. Watch MBX Biosciences stock price performance more closely on the chart.
What is MBX Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange MBX Biosciences stocks are traded under the ticker MBX.
Is MBX Biosciences stock price growing?▼
MBX stock has risen by +3.63% compared to the previous week, the month change is a -6.9% fall, over the last year MBX Biosciences has showed a +479.27% increase.
What is MBX Biosciences market cap?▼
Today MBX Biosciences has the market capitalization of 3.05B
When is the next MBX Biosciences earnings date?▼
MBX Biosciences is going to release the next earnings report on November 05, 2026.
What were MBX Biosciences earnings last quarter?▼
MBX earnings for the last quarter are -0.78 USD per share, whereas the estimation was -0.63 USD resulting in a -23.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MBX Biosciences revenue for the last year?▼
MBX Biosciences revenue for the last year amounts to 0 USD.
What is MBX Biosciences net income for the last year?▼
MBX net income for the last year is -86.97M USD.
How many employees does MBX Biosciences have?▼
As of September 08, 2026, the company has 63 employees.
In which sector is MBX Biosciences located?▼
MBX Biosciences operates in the Health & Wellness sector.
When did MBX Biosciences complete a stock split?▼
MBX Biosciences has not had any recent stock splits.
Where is MBX Biosciences headquartered?▼
MBX Biosciences is headquartered in CARMEL, United States.